Based on diverse activities and production of several cytokines, T lymphocytes and T helper cells are divided into Th1, Th2, Th17 and regulatory T-cell (T regs) subsets based on diverse activities and production of several 
Introduction
The existence of regulatory T-cell was first suggested over two decades ago, but since then a lot of questions about their structure and function remains unanswered. These cells have the ability to regulate innate and adaptive immune responses, especially cellular immunity (Hasanjani et al., 2016; Ranjbar et al., 2012; Yazdani et al., 2015) . Although, it has been proven that Th1cells are more susceptible to the suppressive activity of Treg cells than Th2 cells (Cools, Ponsaerts, Van Tendeloo, & Berneman, 2007; Thunberg et al., 2010) . These suppressive cells were first recognized by their expression of a phenotype marker called CD25 .Howbeit, CD25 is an activation marker, it is also present on the surface of the T helper cells, too. Several the subsets of Tregs include natural regulatory T-cells, Th3 cells, Tr1 regulatory cells, CD8+ Treg and natural killer like Treg (NKTreg) cells.
Natural Regulatory Tcells (nTregs)
As a subpopulation of immunoregulatory T-cells , Natural Regulatory Tcells constitutes nearly 5%-10% of CD4+ cells circulating in the bloodstream of humans (Sakaguchi, 2005) . In spite of , CD25 is an activation marker of Tcells, less than 5% of cells with high expression levels of this marker have been proposed as a regulatory agent (Costantino, Baecher-Allan, & Hafler, 2008) . Other markers of nTregs include OX40,CD62 ligand, CTLA4 and Forkhead family transcription factor (FOXP3), among them which only a high level of intracellular FOXP3 is a specific molecular marker for distinction between activated regulatory T-cells and other cells like activated CD4+ T-cells (Hori, Nomura, & Sakaguchi, 2003) . It was proven that the transcription factor FOXP3 has a crucial role in generation, thymocyte differentiation and function of nTregs in mice (Ramsdell & Ziegler, 2003) . There is also correlations exist between lack of FOXP3 protein expression and scurfy in mice or as well as immune dysregulation, polyendocrinopathy, enteropathy and X-linked syndrome (IPEX) in humans (MohammadniaAfrouzi et al., 2015) . In other words, the transcription factor FOXP3 is mutated in such like diseases (Gambineri, Torgerson, & Ochs, 2003; van der Vliet & Nieuwenhuis, 2007) .Contrary to, some recent studies reject the role of this marker in many case of autoimmune diseases (Costantino et al., 2008) .Cytokines are type of soluble glycoproteins produced by a wide variety of cells, mainly leukocytes within the effector periods of immunity and which regulate immune and inflammatory responses. TGF-beta is a necessary cytokine that is capable of inducing the expression of Foxp3. Bone Morphogenetic Proteins (BMPs) are a specific group of proteins within the members of TGF-beta superfamily, which Smight replace with TGF-β during the development of Tregs. As well as, BMPs can also regulate the differentiation, proliferation and apoptosis of various cell types (Ling Lu et al., 2010) . Studies on the effect of other cytokines showed that, TNF-α decreases the repressive function of peripheral blood Treg cells in inflammatory bowel diseases (IBD), In so doing, anti-TNF treatment causes to decline in regulatory cells apoptosis or recovery of Tregs percentage (Boschetti et al., 2011; Guidi et al., 2013) . IL-15 as a secreted cytokine by mononuclear phagocytes increments expression of regulatory T-cell FOXP3 in the absence of antigenic stimulation. Also it has been shown that FOXP3 expression in the presence of IL-2 and IL-15 compared to IL-7 is significantly increased (Imamichi, Sereti, & Lane, 2008) . IL-27Rα is expressed at high levels in the Tregs. IL-27 is capable of binding to IL-27Rα as well as promoting nTreg cell expansion in response to IFN-γ and it is specifically controls of Th1 and as well as expression of CXCR3 on the surface of regulatory cells in intracellular pathogen infections (Hall et al., 2012) . IL-2, IL-4 and IL-7 are common gamma chain cytokines. IL-4 and IL-7 are not necessary for the function of nTreg but are important as survival factors (Long & Buckner, 2008) . Compared with them, IL-2 is required for both the activity and homeostasis of nTreg (Zorn et al., 2006) . Although, a number of researches do not confirm this issue (Davidson, DiPaolo, Andersson, & Shevach, 2007) .
Th3 Regulatory Cells
This subset of Treg was first isolated from Mesenteric lymph node (MLN) of mice tolerated by low dose antigen feeding(X. Wang et al., 2013) . Th3 regulatory cells are dependents upon TGF-ß and expresses latency-associated peptide (LAP) on own their surface. In the other words, LAP-expressing Tregs are capable of more further suppressive activity in a TGFβ-dependent manner. LAP as a marker be highly expressed on activated Tregs and platelets.(Howard L Weiner, da Cunha, Quintana, & Wu, 2011) Antigen presenting cells(APCs) induces Th3, however this effect is amplificated by IL-4, IL-10 and TGFβ (Seder et al., 1998) . Among them, TGF-β can increase the differentiation of Th3, a process that can be intensified by anti IL-12(Howard L. Weiner, 2001 ). Albeit, TGF-β can suppress T-cell proliferation and cytotoxicity. TGF-β1 secreted by Th3 is shown to play an incisive role in oral tolerance, as it suppresses of Th1/Th2 balance and cytokine production in Th1 . Th3 cells express another molecule called cytotoxic T-lymphocyte antigen 4 (CTLA-4) on their surface. CTLA-4 cells compete with the binding of B7 ligands to CD28, which inhibit the growth and function of T-cells. Also, CTLA-4 as an effective marker has been shown to induce the production TGF-β, and with increasing proportion of anti-CTLA-4 signaling antibody, TGF-β production is equally reduced (Myint, Leonard, Steinbusch, & Kim, 2005) . This regulator cells cause to extensive release of IgA antibodies from plasma cells too much. Overall, Th3 has a regulatory role in homeostasis and gastrointestinal diseases (Akbari, Stock, DeKruyff, & Umetsu, 2003; W. Chen, Jin, & Wahl, 1998) .
Tr1 Regulatory Cells
This subset of regulatory cells is described by a unique cytokine production profile: they produce high levels of TGF-β and IL-10 but low levels of IFN-γ , IL-5 and IL-2 (Allan et al., 2008) . The cytokine secretion pattern of Tr1 to distinguish it from other T-cells is very helpful. Tr1 cells are capable of controlling immunologic tolerance and auto immune diseases. Some studies showed that IL-10 is a key immunoregulator during viruses, bacteria, parasites infection and decreases immunopathology in many infections. The Th2-associated cytokines IL-4 and IL-13 all perform necessary roles in the pathogenesis of schistosomiasis, with IL-4 and IL-13 directing acute fibrosis. It is has been confirmed that, IL-10 in keeping IL-12 controls Th2 response as described in Schistosoma mansoni involvement (Couper, Blount, & Riley, 2008) .The recent studies indicate the effects of IL-10 on the proliferation and differtiation of human peripheral blood T-cells with inhibition of IL-2 and IL-5 secretion or blocking the production of some chemokines in APCs (Moore, de Waal Malefyt, Coffman, & O'Garra, 2001 ). In addition, IL-10 is effective on T-cells function via suppression of CD28 (O'Garra, Vieira, Vieira, & Goldfeld, 2004) . IL-10 inhibits the production of proinflammatory cytokines and CD80/86 molecules in monocytes. IgE synthesis in humoral system could be suppressed by this Tr1 cytokine (Meiler, Klunker, Zimmermann, Akdis, & Akdis, 2008) . IL-6 and IL-27 , which are both amplified by TGF-β, boost the production of IL-10 by Tr1 and Th17 cells (Couper et al., 2008) . Tr1 cells express some functional markers such as: HLA-DR,CD-40L, IL-15Rα,IL-2Ry and various chemokine receptors CCR5, CCR3,CCR8 and CXCR3 (Battaglia, Gregori, Bacchetta, & Roncarolo, 2006) . Presence of Tr1 cells in joint fluid and blood specimens from rheumatoid arthritis (RA)patients, confirm this cells effectiveness in immune response (Berthelot & Maugars, 2004) .Role of Tr1 in controlling of type 1 diabetes (T1D) in both of human and mouse model was demonstrated, even the deficiency of Tr1 cells in T1D patients has been investigated (Bettini & Vignali, 2009 ).
Tr1 suppresses the effector cells of allergic inflammation, such as mast cells, eosinophils and basophils. Therefore, some experts emphasize for getting help of Tr1 in developing new strategies for treatment of allergic diseases(K. Wu, Bi, Sun, & Wang, 2007) .
CD8 + Regulatory Cells
In recent years, another type of suppressor cells has been introduced. These cells are known as CD8 + regulatory cells(H. Jiang & Chess, 2000) . They are not part of CD4 + regulatory cells and have not cytotoxicity but inhibit the immune response especially TCD4 + cells in an Ag-specific manner within MHC class I (Vlad, Cortesini, & SuciuFoca, 2005) . CD8 + regulatory cells express FOXP3 (not mouse), high levels of CTLA-4 and low level of CD127, which is helpful for differentiation with CD4 + Treg (Fontenot et al., 2005; Scotto et al., 2004) . Many studies were showed that CD8 + regulatory cells expressed glucocorticoid-induced tumor necrosis factor receptor (GITR) and tumor necrosis factor receptor 2 (TNFR2), which were identified in human thymus (Cosmi et al., 2003) . Usefulness of these cells in treatment was first demonstrated in animal models of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) (Linrong Lu & Cantor, 2008 ). Some researches demonstrate that CD8 + regulatory cells are presented in the lamina proparia of healthy cases, but not in IBD patients, suggesting that these cells might play a crucial role in immune tolerance in this involvement or in several cancers (Brimnes et al., 2005; Dinesh, Skaggs, Cava, Hahn, & Singh, 2010) .
NKT Regulatory Cells
Several researchers have proposed other names for these cells, including natural T-cells,Vα14i T-cells and iNKTcells. Although NKT-cells has been accepted and is now used to refer to these suppressive cells, because they simultaneously express some markers of NKcells and T-cells. These markers contain CD161(human), NK1.1( mouse),CD16 and IL-2Rẞ as NKcells marker and TCRs belonging Tcells (Godfrey, MacDonald, Kronenberg, Smyth, & Van Kaer, 2004) . NKT-cells are localized in various tissues like liver, bone marrow, lung and spleen. Thus, these cells observe within account for 50% of T-cells in the liver, 30% in the bone marrow,7% in lung and 3% in spleen (Tarazona et al., 2003) . Other types of these cells according to expressing of CD markers are included CD4 (Smyth et al., 2002) . NKT regulatory cells play major role in regulation of immune responses in allergy, infection and cancer. Many studies have showed that the proportion of NKT regulatory cells increased in the lung after Mycobacterial and Streptococcus pneumoniae infections (Iwamura et al., 2012) .
Mechanism of Suppression
Although, the crucial role of Tregs in regulation of physiologic and pathologic responses including anti tumor and anti bacterial effects has confirmed but, no clearly description has been presented for mechanism of Tregs suppression. Suppression of T-cells is either mediated by cell-cell contact and immunosuppressive cytokines.
Cell-Cell Contact
Natural (human) Tregs and CD4 + CD25 + (mouse) Tregs express CTLA-4 or CD152. It has been postulated that CD152 is necessary for the function of these cells. CTLA-4 competes with CD28 for binding to B7. The affinity of CTLA4 for B7 was estimated to be about 10 folds higher than the affinity of CD28 for this ligand. T-cell proliferation is inhibited by binding of CTLA-4 to B7, in other words CTLA-4 plays an important role in T-cell peripheral tolerance (Salomon et al., 2000) . Tregs stimulate dendritic cells (DCs) to express the enzyme indoleamine 2,3-dioxygenase (IDO) or IDO production is resulted from interactions between CTLA-4 and B7 ligands. Although, these cells may block the expression of B7-1 and B7-2 on some APCs (Sakaguchi, Wing, Onishi, Prieto-Martin, & Yamaguchi, 2009) . IDO Serves tryptophan to kynurenine, leading to destruction of T-cells and also to direcT-cell cycle suppression. Many researches were showed that IDO causes to tryptophan degradation and suppress the immunity response to tumors (Soliman, Mediavilla-Varela, & Antonia, 2010) . Autoimmune disorders widely occur in CTLA-4 deficient mice widely and the ability of repression in Treg is reduced (Vogel et al., 2015) . Moreover, CTLA-4/CD80.86 interactions to the control of colitis were clearly described (Sojka, Huang, & Fowell, 2008) .
Immunosuppressive Cytokine Mediated Suppression
TGF-ß and IL-10 have great role in the suppression of immune system. TGFβ decreases the expression of MHC class II in macrophages and DCs. In astrocyte ( a sub-type of glial cells in the central nervous system or CNS), class II MHC transactivator (CIITA), as a suppressor that regulates MHCII expression, is targeted by TGF-β for repression of MHCII expression (Dong, Tang, Letterio, & Benveniste, 2001 ). Totally, TGF-β suppresses immunity system via in two manners: promoting the function of Treg cells especially in autoimmune diseases and suppression of inflammatory cells. It should be noted that , the role of TGF-β in Tregs suppression is still an issue of argument (Oberle, Eberhardt, Falk, Krammer, & Suri-Payer, 2007) . In preliminary mechanism of suppression, IL-10 inhibits the expression of cell surface MHC II by macrophages. In this regard, IL-10 diminishes mRNA as to MHC II and expression of this MHC in peritoneal macrophage (Chadban et al., 1998) . Contrary, IFN-γ stimulates the expression of MCHII molecules on mesangial cells and IL-10 and TGF-β regulate this function (Gattoni, Parlato, Vangieri, Bresciani, & Derna, 2006) . Other cytokines like IL-35 are produced by Tregs (Bardel, Larousserie, Charlot-Rabiega, Coulomb-L'Herminé, & Devergne, 2008; Collison et al., 2007) . In cancer cells, IL-35 increases the expression of gp130 and decreases sensitivity to cytotoxic T-cell (CTL) demolition. More over IL-35 promotes tumor angiogenesis(Z. Wang et al.) .
Regulatory T-cell and Infection

Regulatory T-cells in Viral Infections
It is confirmed that infections are associated with various regulatory cells and their cytokines. For example, IL-10 plays a key role in several disorders, including ; hepatitis C, Tuberculosis and Leishmaniasis, as a suppressor of immune systems (Wohlfert & Belkaid, 2008) . TCD8 + cell response during acute viral infection is necessary for elimination of virus. But however, Tregs cause to limit in this function and some experiments were showed that clearing the viruses is accelerated without regulatory cells. Virus-specific T-cells can cause to damage to the host tissues, but Treg cells prevent tissues damage and are beneficial. Increase in regulatory T-cells has been shown to suppressive activity in the acute form of HCV patients (Sugimoto et al., 2003) . These regulatory cells may also protect the patients from pathologic disorders and viral-induced inflammation in chronic HCV infection(Claassen, (Rouse, Sarangi, & Suvas, 2006) . This was supported by the fact that, depletion of Tregs from cases with HSV infection significantly enhanced the protective immunity (Fernandez et al., 2008 ). In HIV infection the level of regulatory T-cells in lymph nodes and blood may be significantly high. Treg cells mainly suppress cytokines secretion of CD4 + T-cells and cytolytic activity of CD8 + effector T-cells in acute phase of infection more than chronic phase (Thorborn et al., 2010) . According to some studies, presence of viraemia in chronic HIV infection is correlated with the reduction of circulating regulatory T-cells which is useful to enhancement of CD4 + T-cells function (Baker et al., 2007) . Overall, researches indicate that chronic viral infection cause to induce regulatory T-cells which are implicated in the regulation and impairment of antiviral immune responses.
Regulatory T-cells in Bacterial Infections
In bacterial infections like active form of tuberculosis (TB), Treg cells meaningfully expand in the lung, blood and lymph nodes relative to healthy or latent cases (Y. E. Wu et al., 2010) . CD4 + CD25 + FoxP3 + T-cells are able to suppressing IL-10 and IFN-γ production in TB patients (Xinchun Chen et al., 2007) . Regulatory T-cells prevent from disruption of tubercle bacilli by suppressing efficient CD4 + T-cell response in TB. In these infections like viral disorders, Tregs have some beneficially aspects for host, as could they permit a long-term persistence of M. tuberculosis and thus a relative maintained immunity against re-infection (Majlessi, Lo-Man, & Leclerc, 2008) . In Bordetella pertussis infection, the virulence factor of these bactria is toxin (PTx). This toxin causes to enhanced function of regulatory T-cells and promoted in TGF-ß in the serum of cases and thus Bordetella pertussis inhibits Th1 response (Weber et al., 2010) . Also other studies showed that PTx cause to down-regulation of the percentage and function of Treg cells and this element is used to induce murine experimental autoimmune encephalomyelitis (EAE) (Xin Chen et al., 2006) . During infection with Brucella abortus, similar to other infectious models, there is increase in both effector CD4 + T-cells and regulatory T-cells in the spleen of BALB/c mice (Pasquali et al., 2010) . Due to this fact, Treg cells inhibit Th1 activity and used to process of infection (Hasanjani-Roushan, Kazemi, FallahRostami, & Ebrahimpour; Kazemi, Damavandi, & Ebrahimpour, 2015; Roushan, Kazemi, Rostam, & Ebrahimpour, jmbr.ccsenet.org Journal of Molecular Biology Research Vol. 7, No. 1; 2017 13 2014). Furthermore, this is showed that the percentage of regulatory T-cells was shown to be elevated in several forms of human brucellosis, and also, this increment being rather in the chronic patients (Bahador et al., 2014) . CD4 + CD25 + T regulatory cells, which produce IL-10 mediated alteration in macrophages function, therefore impede CD4 + T-cell response. In infection with Salmonella Typhimurium, when the bacterial burden is increasing, Treg cells suppress the activity and proliferation of some immune cells But, when bacterial load is decreased, the suppression ability of Treg cells is declined (Johanns, Ertelt, Rowe, & Way, 2010) .
Regulatory T-cells in Parasitic Infections
In parasitic infection, immune response depends on activity of Th2 and cytokines as IL-4, IL-5 and IL-13. CD4 Th2 responses and also are correlated with increased IL-10 production. Thus, regulatory T-cells prohibit complete elimination of parasites from the skin of host, during cure of infection (Nylén & Sacks, 2007) .
Regulatory T-cells in Fungal Infections
Aspergillosis is caused by the spores of Aspergillus, and can occur depending on the functions of Th 1, Th2, Th17, and regulatory T-cells. CD4 + T-cells can protect the host against invasive aspergillosis (Bozza et al., 2009 ). Treg cells prevent innate immune cells and effector Tcells by suppressing the production of inflammatory cytokines. Thus, activation and expansion of Treg cells able to regulate neutrophils within the action of IL-10 on indoleamine 2,3-dioxygenase(IDO) that leads to control of inflammation in this fungal infection (Montagnoli et al., 2006) . Some studies showed a higher percentage of CD4 + CD25 + Foxp3 + T-cells and increased GITR expression levels of these cells in cases with active paracoccidioidomycosis (an infection caused by the dimorphic fungus Paracoccidioides brasiliensis) and also indicated that after adequate antifungal therapy, the levels of regulatory T-cells was declined in the circulation (Ferreira, de Oliveira, da Silva, Blotta, & Mamoni, 2010) . Furthermore, an important receptor called CCR5 caused to migration of regulatory T-cells to the lesions of paracoccidioidomycosis, leading to suppression of immune response and lasting attendance of Paracoccidioides brasiliensis in the granulomas (Moreira et al., 2008) . So, a useful mechanism for avoiding the intensity of infection is regulation of this migration to the lesions. In Candida albicans infection, the immune response contains production of cytokines as IL-1, IL-17A and IFN-γ (Zelante et al., 2007) . Th1 cells are associated with protection from this infection. However, the presence of regulatory T-cells inhibits clearance of C. albicans with macrophages. Contrary to , other studies administrated that in C. albicans involvements , elevated percentage of Treg cells correlated to protection from infection, as in some autoimmune diseases with faulty regulatory Tcells, mucocutaneous candidiasis were observed (Whibley et al., 2014) . 
Parasitic infection
Increased (Belkaid, 2007) Fungi infection Increased (Ferreira et al., 2010; Romani, 2004) Multiple sclerosis Normal or decreased (Haas et al., 2007; Huan et al., 2005) Idiopathic thrombocytopenic purpura (ITP) Decreased (Lv, Liu, & Wu, 2007) Type 1 diabetes Decreased (Lindley et al., 2005) Ulcerative colitis Normal or decreased (Takahashi et al., 2006) Cancer Increased (Mougiakakos, Choudhury, Lladser, Kiessling, & Johansson, 2010) jmbr.ccsenet.org Vol. 7, No. 1; Figure 1. Level of regulatory T-cells in different disorders
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In conclusion, in spite of many studies on control and suppression of immune system including cells and tissues involved, many questions regarding to aspects of these issues remain unanswered. According to currently discussed text, Treg cells play a dual role as immune regulatory cells are dual, thus these cells suppress infectious immune response and also moderateing the immunopathologic effects of some disease causing agents. Of course, it seems that inadequacy of the advantage of this simple protection. Such abilities of the Treg cells in association with the infectious immune responses make them remarkable models to achieve new strategies in the treatment of infectious diseases.
